alexa Editor - Eduardo Seclen Hidalgo | University of Southern Califor | 19638

Journal of Molecular Immunology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Eduardo Seclen Hidalgo

Eduardo Seclen Hidalgo
Eduardo Seclen Hidalgo
Molecular Microbiology and Immunology
Univ. of Southern California
USA
University of Southern California

Biography

Eduardo Seclen Hidalgo a Research Associate at the University of Southern California, where he works in in hematopoietic stem cells focused on HIV research. He obtained his PhD from the University of Complutense in Madrid, Spain studying ways to characterize HIV viral tropism, and its impact in the pathogenesis of the infection and response to antiretroviral treatment. In the last 3 years, his research have been enriched by his participation in projects using gene therapy in hematopoietic stem cells as an approach to fight genetic and infectious diseases, including HIV.
His research have been funded by prestigious fellowships provided by the AIDS foundation “Fundación de Investigación y Prevención del SIDA en España”, the National Health Institution “Instituto de Salud Carlos III” and, more recently, the “California Institute for Regenerative Medicine”.

Research Interest

HIV virology
HIV tropism
HIV pathogenesis
Antiretroviral treatment, especially entry inhibitors
Bone marrow transplantation as approach to fight HIV
Gene therapy in stem cells as approach to fight infectious diseases, including HIV
HIV latency, especially use of vectors to disrupt latency in vivo and mouse models

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7
Top